Alerts
View all our safety alerts, medicine shortage alerts and product recalls.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Breast implant hub (2)
- (-) Weight loss products (1)
- Alert/Advisory (1067)
- Medicine safety (493)
- Medical devices safety (343)
- Safety (61)
- Regulatory compliance (23)
- Import and export (18)
- Listed medicines (16)
- Prescription medicines (16)
- Over the counter (OTC) medicines (14)
- Therapeutic goods regulation (14)
- Complementary medicines (12)
- Australian Register of Therapeutic Goods (ARTG) (11)
- Shortages (11)
- Blood safety (8)
- Non-prescription medicines (7)
- Advertising (4)
- Labelling and packaging (3)
- Sunscreens (3)
- Legislation (2)
- Assessed listed medicines (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
Search
3 result(s) found, displaying 1 to 3
-
Safety alertsFurther examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.
-
Safety alertsOn 8 September 2022, the US Food and Drug Administration issued a safety communication about reports of squamous cell carcinoma and various lymphomas located in the capsule or scar tissue around breast implants.
-
Safety alertsUpdate - Suspended breast implant devices now cancelled